PROVIDER PROFILE · NPI 1053606962
Melissa Martinez
PRESCRIBING · PART D · 2024
Total Rx claims
316
Beneficiaries
—
Total drug cost
$2.5M
Distinct drugs
11
Brand share
55.1%
Top prescribed drugs
Osimertinib Mesylate132 claims
Ondansetron Hcl30 claims
Alectinib Hcl26 claims
Tenofovir Disoproxil Fumarate24 claims
Prochlorperazine Maleate18 claims
CROSS-REFERENCE